chronic hepatitis B raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-31 and is reviewed periodically as new material appears.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | 28 residues; not a small-molecule compound |
| Molecular mass | About 3,106 Da | Monoisotopic mass of the unmodified chain |
| N-terminal group | Acetylated serine | Present in both native and synthetic forms |
| Secondary structure | Disulfide-constrained loop | One bridge between two cysteine residues |
| Typical source | Solid-phase synthesis | Early isolates came from bovine thymus extracts |
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Negative-pressure wound therapy (NPWT), also known as a vacuum assisted closure (VAC), is a therapeutic technique using a suction pump, tubing, and a dressing to remove excess wound exudate and to promote healing in acute or chronic wounds and second- and third-degree burns. The use of this technique in wound management started in the 1990s and this technique is often recommended for treatment of a range of wounds including dehisced surgical wounds, closed surgical wounds, open abdominal wounds, open fractures, pressure injuries or pressure ulcers, diabetic foot ulcers, venous insufficiency ulcers, some types of skin grafts, burns, and sternal wounds. It may also be considered after a clean surgery in a person who is obese. NPWT is performed by applying a sub-atmospheric vacuum through a special sealed dressing. The continued vacuum draws out fluid from the wound and increases blood flow to the area. The vacuum may be applied continuously or intermittently, depending on the type of wound being treated and the clinical objectives. Typically, the dressing is changed two to three times per week. The dressings used for the technique include foam dressings, sealed with an occlusive dressing intended to contain the vacuum at the wound site. Where NPWT devices allow delivery of fluids, such as saline or antibiotics to irrigate the wound, intermittent removal of used fluid supports the cleaning and drainage of the wound bed. In 1995, Kinetic Concepts was the first company to have a NPWT product cleared by the US Food and Drug Administration.
Country Style is a chain of coffee stores operating primarily in the province of Ontario. They have 420 estimated locations in Canada. Country Style was purchased by MTY Food Group Inc. With their headquarters located in Richmond Hill, Ontario.
== See also == Air-free technique – Chemistry laboratory technique Acidic oxide – Type of oxide, a.k.a. acid anhydride Base anhydride – Oxide of a chemical element from alkali- or alkaline earth metals Hydrate – Substance containing water or its constituent elements
== In various fields == As a central goal of many individual and societal endeavors, well-being is relevant to many fields of inquiry. Grouped under the umbrella term science of well-being, some disciplines investigate the nature and components of well-being directly, while others study its causes, effects, or correlates in specific domains of life. A central motivation of academic inquiry is the belief that well-being can be improved through appropriate measures. Some of these measures focus on individual lifestyle changes. Others take the form of societal interventions to alter how economic, medical, educational, workplace, and political institutions function.
Sources: en.wikipedia.org
== Pathophysiology == Normal glucose homeostasis is controlled by three interrelated processes. These processes include gluconeogenesis (glucose production that occurs in the liver), uptake and utilization of glucose by the peripheral tissues of the body, and insulin secretion by the pancreatic beta islet cells. The presence of glucose in the bloodstream triggers the production and release of insulin from the pancreas' beta islet cells. The main function of insulin is to increase the rate of transport of glucose from the bloodstream into certain cells of the body, such as striated muscles, fibroblasts, and fat cells. It also is necessary for transport of amino acids, glycogen formation in the liver and skeletal muscles, triglyceride formation from glucose, nucleic acid synthesis, and protein synthesis. In individuals with prediabetes, a failure of pancreatic hormone release, failure of targeted tissues to respond to the insulin present or both leads to blood glucose rises to abnormally high levels.
Bradbury AF, Finnie MD, Smyth DG (1982). "Mechanism of C-terminal amide formation by pituitary enzymes". Nature. 298 (5875): 686–8. Bibcode:1982Natur.298..686B. doi:10.1038/298686a0. PMID 7099265. S2CID 4324776. Bradbury AF, Smyth DG (1987). "Enzyme-catalysed peptide amidation. Isolation of a stable intermediate formed by reaction of the amidating enzyme with an imino acid". Eur. J. Biochem. 169 (3): 579–84. doi:10.1111/j.1432-1033.1987.tb13648.x. PMID 3691506. Glembotski CC (1985). "Further characterization of the peptidyl alpha-amidating enzyme in rat anterior pituitary secretory granules". Arch. Biochem. Biophys. 241 (2): 673–83. doi:10.1016/0003-9861(85)90594-6. PMID 2994573. Katopodis AG, Ping D, May SW (1990). "A novel enzyme from bovine neurointermediate pituitary catalyzes dealkylation of alpha-hydroxyglycine derivatives, thereby functioning sequentially with peptidylglycine alpha-amidating monooxygenase in peptide amidation". Biochemistry. 29 (26): 6115–20. doi:10.1021/bi00478a001. PMID 2207061. Murthy AS, Keutmann HT, Eipper BA (1987). "Further characterization of peptidylglycine alpha-amidating monooxygenase from bovine neurointermediate pituitary". Mol. Endocrinol. 1 (4): 290–9. doi:10.1210/mend-1-4-290. PMID 3453894. Murthy AS, Mains RE, Eipper BA (1986). "Purification and characterization of peptidylglycine alpha-amidating monooxygenase from bovine neurointermediate pituitary". J. Biol. Chem. 261 (4): 1815–22. doi:10.1016/S0021-9258(17)36013-1. PMID 3944110.
Jack Schmidt was the first person commissioned to paint the original In-N-Out located in Baldwin Park, California for In-N-Out Burger Inc. His paintings were later reproduced on advertisements, shirts, and other consumer products. The 2022 shirt design was created by Palm Springs, California artist Danny Heller.
It is not known how to compensate for the absence of liver function in the long term, although liver dialysis techniques can be used in the short term. Artificial livers have not been developed to promote long-term replacement in the absence of the liver. As of 2018, liver transplantation is the only option for complete liver failure. The liver is the largest internal organ in vertebrates and its structure is similar in all other vertebrates. It is mostly divided into right and left lobes.
osmosis The spontaneous net movement or diffusion of molecules of a solvent (e.g. water) through a selectively permeable membrane separating two solutions with different concentrations of dissolved solutes, in the direction that tends to equalize the solute concentrations on the two sides, i.e. from the more dilute solution to the more concentrated solution, or, equivalently, from a region of high water potential to a region of low water potential. Because the solute is unable to cross the membrane, the tendency towards equilibration compels the solvent to cross the membrane instead. This continues until an equilibrium is reached, where neither side of the membrane is more or less concentrated than the other.
Sources: en.wikipedia.org
The United States entered World War I alongside the Allies in 1917 helping to turn the tide against the Central Powers. In 1920, a constitutional amendment granted nationwide women's suffrage. During the 1920s and 1930s, radio for mass communication and early television transformed communications nationwide. The Wall Street Crash of 1929 had triggered the Great Depression, to which President Franklin D. Roosevelt responded with the New Deal plan of "reform, recovery and relief", a series of unprecedented and sweeping recovery programs and employment relief projects combined with financial reforms and regulations. During the 1930s, severe drought and dust storms caused or exacerbated by poor agricultural practices forced hundreds of thousands of displaced farming families (often called "Okies" because many originated from Oklahoma) to migrate from the Great Plains to California in search of subsistence. Initially neutral during World War II, the U.S. began supplying war materiel to the Allies of World War II in March 1941 and entered the war in December after Japan's attack on Pearl Harbor. Agreeing to a "Europe first" policy, the U.S. concentrated its wartime efforts on Japan's allies Italy and Germany until their final defeat in May 1945. The U.S. developed the first nuclear weapons and used them against the Japanese cities of Hiroshima and Nagasaki in August 1945, which historians consider central to the end of World War II in Asia.
A bound system is typically at a lower energy level than its unbound constituents because its mass must be less than the total mass of its unbound constituents. For systems with low binding energies, this "lost" mass after binding may be fractionally small, whereas for systems with high binding energies, the missing mass may be an easily measurable fraction. This missing mass may be lost during the process of binding as energy in the form of heat or light, with the removed energy corresponding to the removed mass through Einstein's equation E = mc2. In the process of binding, the constituents of the system might enter higher energy states of the nucleus/atom/molecule while retaining their mass, and because of this, it is necessary that they are removed from the system before its mass can decrease. Once the system cools to normal temperatures and returns to ground states regarding energy levels, it will contain less mass than when it first combined and was at high energy. This loss of heat represents the "mass deficit", and the heat itself retains the mass that was lost (from the point of view of the initial system). This mass will appear in any other system that absorbs the heat and gains thermal energy. For example, if two objects are attracting each other in space through their gravitational field, the attraction force accelerates the objects, increasing their velocity, which converts their potential energy (gravity) into kinetic energy.
=== MSIR model === For many infections, including measles, babies are not born into the susceptible compartment but are immune to the disease for the first few months of life due to protection from maternal antibodies (passed across the placenta and additionally through colostrum). This is called passive immunity. This added detail can be shown by including an M class (for maternally derived immunity) at the beginning of the model.
Parliament passes the Electoral Amendment Act 2025, which tightens the timeframe for voter registration, bans prisoners from voting, and allows larger anonymous political donations. 17 December: Assistant Commissioner Mike Pannett is appointed as Deputy Police Commissioner. The New Zealand Government agrees to return 3,068 hectares in the upper South Island, including the Kaiteriteri Recreation Reserve and the Abel Tasman Coast Track, plus a $420 million compensation, to Te Tau Ihu Māori as part of the Nelson Tenths settlement. Former Deputy Police Commissioner Jevon McSkimming is sentenced to nine months of home detention after pleading guilty to charges of possessing objectionable material. Primary school teachers affiliated with the New Zealand Educational Institute reject the Government's pay off of a 4.6% pay rise over the next two years. Justice Michele Wilkinson-Smith of the Wellington High Court rules in favour of PATHA's bid to delay an incoming ban on new puberty blocker prescriptions expected to come into effect on 19 December, pending a judicial review. Justice Pheroze Jagose of the Auckland High Court dismisses food processing company Talley's Group's defamation case against broadcaster TVNZ and journalist Thomas Mead over a 2021 story covering its Ashburton plant. One new case of measles is reported in Queenstown, bringing the total number of cases nationwide to 32. Four cases were active at the time.
Sources: en.wikipedia.org
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.
The single bridge between two cysteine residues holds the chain in a folded loop that influences its shape and its behavior in solution. Loss of the bridge through reduction or oxidation shifts chromatographic retention and is tracked during stability work.
It is a defined 28-residue sequence derived from a larger precursor, whereas many other thymic preparations are mixtures of several polypeptides. Its acetylated amino terminus and single disulfide bridge distinguish it chemically from unrelated thymic extracts.
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.